Overview

Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy

Status:
COMPLETED
Trial end date:
2024-05-13
Target enrollment:
Participant gender:
Summary
Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy
Phase:
PHASE3
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical
Treatments:
2-(3,4-dimethoxyphenyl)-8-(4-hydroxy-3-methoxyphenyl)-6-methyl-2-isopropyl-6-azaoctanitrile